A Phase 1, Corplex™ Donepezil Transdermal System Compared to Oral Aricept®

PHASE1CompletedINTERVENTIONAL

Enrollment

107

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

July 11, 2017

Study Completion Date

July 11, 2017

Conditions

Alzheimer Disease

Interventions

DRUG

Donepezil TDS Version A

Donepezil Hydrochloride Transdermal Delivery System (5mg and 10 mg Version B)

DRUG

Donepezil TDS Version B

Donepezil Hydrochloride Transdermal Delivery System (5 mg and 10 mg Version B)

DRUG

Aricept

Aricept (5 mg and 10 mg) Donepezil Hydrochloride

DRUG

Donepezil TDS Version D

Donepezil Hydrochloride Transdermal Delivery System (5 mg Version D)

DRUG

Donepezil TDS Version E

Donepezil Hydrochloride Transdermal Delivery System (5 mg Version E)

Trial Locations (1)

Celerion, Phoenix

All Listed Sponsors

lead

Corium, Inc.

INDUSTRY

NCT02968719 - A Phase 1, Corplex™ Donepezil Transdermal System Compared to Oral Aricept® | Biotech Hunter | Biotech Hunter